Collegium Pharmaceutical Inc (COLL)
29.06
-0.09
(-0.31%)
USD |
NASDAQ |
Dec 24, 16:00
Collegium Pharmaceutical Cash from Investing (Quarterly): -248.96M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 34.27M |
| Insmed Inc | -1.003B |
| Pulmonx Corp | 6.751M |
| RxSight Inc | -9.26M |
| PROCEPT BioRobotics Corp | -0.246M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.999M |
| Cash from Financing (Quarterly) | 149.03M |
| Free Cash Flow | 192.43M |
| Free Cash Flow Per Share (Quarterly) | -0.2301 |
| Free Cash Flow to Equity (Quarterly) | -323.62M |
| Free Cash Flow to Firm (Quarterly) | -0.1872M |
| Free Cash Flow Yield | 14.42% |